As the 2026 investment window opens, some high-quality assets have already shown strong growth potential. For investors, although February is brief, it is a critical period not to be missed for strategic positioning. The following three stocks demonstrate outstanding advantages in performance, industry outlook, and dividend returns, making them worthy of special attention.
Over the past 12 months, Amazon’s stock price has occasionally lagged behind the S&P 500, but the steady growth in corporate earnings often ultimately reflects in its stock performance. Thanks to continuous improvements in operational efficiency, the company’s profitability has significantly strengthened—a trend expected to continue in the Q4 2025 earnings report due this week.
At the same time, agentic AI is projected to inject strong momentum into Amazon Web Services (AWS) in 2026. As companies increase investments in AI agents and gradually reap returns, AWS already showed accelerated growth in Q3. Its industry-leading cloud business is poised for even greater expansion.
Despite a stock price increase of over 50% in the past year, BeOne Medicines remains one of the undervalued assets in the biotech sector. Its core product, Brukinsa, has become the gold standard for treating various blood cancers, and sales in the U.S. and European markets are expected to continue rising.
Recently, the company’s drug sonrotoclax was approved in China for the treatment of relapsed/refractory mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), with U.S. approval also underway. Additionally, if Phase II clinical data are positive, its new drug BGB-16673 for relapsed/refractory CLL may soon submit an accelerated approval application, further expanding its product pipeline.
For income-oriented investors, Enterprise Products Partners holds significant allocation value in February. This limited partnership (LP) offers a forward dividend yield of up to 6.6% and has raised its dividend for 27 consecutive years, demonstrating remarkable stability.
In 2026, the booming development of AI data centers is expected to become a new growth driver for its performance. The company believes that AI will be one of the two core drivers of natural gas demand growth over the next five years, and its natural gas pipeline business is likely to directly benefit from rising demand.
Overall, these three companies, backed respectively by earnings recovery, product innovation, and structural demand growth, exhibit clear growth logic for 2026. Investors can align these opportunities with their own strategies and make targeted allocations during this short-term window.
